MedTrace Logo

Developing a Symptom List for Children With Cancer

NCT02726815 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-04-04

No results posted yet for this study

Summary

Primary Objective

The aim of this research study is to develop a comprehensive inventory of symptoms that occur in children with advanced cancer who are receiving a specialist palliative care service.

Secondary Objectives

* To assess correlation between parent, child and nurse scores on the Memorial Symptom Assessment Scale (MSAS).
* To identify symptom prevalence in children with advanced cancer as identified by the child/young person (CYP), nurse and parent (to be analysed separately for parent, child and nurse).
* To identify whether there are any symptoms missing from the age appropriate MSAS as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
* To identify whether any items on the age appropriate MSAS are not relevant to the population being studied (to be analysed separately for parent, child and nurse).
* To identify which symptoms cause the most distress as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
* To identify degree of severity of each symptom as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
* To identify which symptoms occur most frequently as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
* To assess the trends between phase of illness and symptom profile, severity and distress.

Conditions

  • Paediatric Oncology Palliative Care

Interventions

OTHER

Questionnaire

Questionnaire based study using a symptom assessment tool

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Anna-Karenia Anderson, MbchB · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02726815 on ClinicalTrials.gov